Page last updated: 2024-09-03

4,4',5'-trimethylazapsoralen and angelicin

4,4',5'-trimethylazapsoralen has been researched along with angelicin in 1 studies

Compound Research Comparison

Studies
(4,4',5'-trimethylazapsoralen)
Trials
(4,4',5'-trimethylazapsoralen)
Recent Studies (post-2010)
(4,4',5'-trimethylazapsoralen)
Studies
(angelicin)
Trials
(angelicin)
Recent Studies (post-2010) (angelicin)
600220178

Protein Interaction Comparison

ProteinTaxonomy4,4',5'-trimethylazapsoralen (IC50)angelicin (IC50)
Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)2.5
Amine oxidase [flavin-containing] A Rattus norvegicus (Norway rat)9
Amine oxidase [flavin-containing] AHomo sapiens (human)0.88
Amine oxidase [flavin-containing] BHomo sapiens (human)2.73

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Pérez-Montoto, LG; Santana, L1

Other Studies

1 other study(ies) available for 4,4',5'-trimethylazapsoralen and angelicin

ArticleYear
Scoring function for DNA-drug docking of anticancer and antiparasitic compounds based on spectral moments of 2D lattice graphs for molecular dynamics trajectories.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Antineoplastic Agents; Antiparasitic Agents; Binding Sites; DNA; Markov Chains; Molecular Dynamics Simulation; Molecular Structure; Monte Carlo Method; Quantitative Structure-Activity Relationship

2009